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Abstract 
Nature has incorporated small photochromic molecules, colloquially termed 
‘photoswitches’, in photoreceptor proteins to sense optical cues in phototaxis and 
vision. While Nature’s ability to employ light-responsive functionalities has long been 
recognized, it was not until recently that scientists designed, synthesized and applied 
synthetic photochromes to manipulate biological processes with the temporal and 
spatial resolution of light. Ion channels in particular have come to the forefront of 
proteins that can be put under the designer control of synthetic photochromes. 
Photochromic ion channel controllers are comprised of three classes, photochromic 
soluble ligands (PCLs), photochromic tethered ligands (PTLs) and photochromic 
crosslinkers (PXs), and in each class ion channel functionality is controlled through 
reversible changes in photochrome structure. By acting as light-dependent ion 
channel agonists, antagonist or modulators, photochromic controllers effectively 
converted a wide range of ion channels, including voltage-gated ion channels, ‘leak 
channels’, tri-, tetra- and pentameric ligand-gated ion channels, and temperature-
sensitive ion channels, into man-made photoreceptors. Control by photochromes is 
reversible, unlike in the case of ‘caged’ compounds, and non-invasive with high 
spatial precision, unlike pharmacology and electrical manipulation. Here, we 
introduce design principles of emerging photochromic molecules that act on ion 
channels and discuss the impact that these molecules are beginning to have on ion 





optochemical genetics, optogenetics, photopharmacology, optical control, 
photochrome, azobenzene, tethered ligand  
McKenzie et al.  3 
	
6.1 Introduction 
In all domains of life optical cues control essential physiological and behavioural 
processes that range from simple forms of phototaxis in unicellular organisms to 
vision in animals. Multiple molecular mechanisms to sense light evolved 
independently in the form of distinct classes of photoreceptor proteins. However, with 
few exceptions (Rizzini et al. 2011), most natural photoreceptors rely on low 
molecular weight (Mr~200-700Da) photochromes that undergo reversible 
conformational changes between two isomers upon photon absorption (Ridge and 
Palczewski 2007; Rockwell and Lagarias 2006). A classic example are rhodopsin 
photoreceptors and their prokaryotic relatives, where the 11-cis-retinal undergoes 
light-induced isomerization (‘switching’) into all-trans-retinal (or all-trans-retinal to 13-
cis-retinal). In most members of the opsin protein family, photoisomerization of retinal 
triggers changes in the structure of the transmembrane protein and activates ion flow 
or activation of downstream signalling cascades. 
New fields of laboratory research have been inspired by Nature’s highly efficient 
concept of relaying light-induced structural changes of small photochromes to larger 
biological molecules. In the past 40 years, photochromes have been combined with 
small peptides, proteins, lipids and nucleic acids (Dynamic Studies in Biology: 
Phototriggers, Photoswitches and Caged Biomolecules  2005). One central 
motivation for this work was found in the recognition that light can be precisely 
controlled in space and time and offers non-invasive ‘remote’ control in transparent 
matrices. Inspired by classic work dating back as far as to the 1970s (Bartels et al. 
1971; Lester et al. 1980; Bieth et al. 1969; Deal et al. 1969), photochromes were 
recently introduced in the ion channel field to contribute these experimental 
advantages to our current research. Researchers began to exploit photochromes 
with the help of molecular, chemical and genetic engineering in the fields of 
photopharmacology and optochemical genetics. New photochromic tools were 
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developed and meanwhile many classes of ion channels have been ‘fitted’ for 
photochromic controllers. 
This chapter will focus on the design and impact of photoswitches in ion channel 
research. In Sections 6.2 and 6.3, we build up photochromic ion channel controllers 
by explaining the structure and function of synthetic photochromes (Section 6.2) and 
the design approach towards PCLs, PTLs and PXs (Section 6.3). In Section 6.4 we 
discuss specific application of photochromes to the different ion channel families. Our 
contribution focuses on photochromes, which are in themselves reversible and 
control ion channels reversibly, and therefore we do not discuss caged compounds, 
photoaffinity labelling or the use of light-sensitive unnatural amino acids. 
 
6.2 Synthetic photochromes for biological research 
By definition, photochromes undergo light-induced and reversible transitions between 
two isomers that exhibit distinct spectral properties. Light-induced changes of colour 
were first reported by Fritzsche for tetracene (Fritzsche 1867) and Hirshberg coined 
the term photochromism (Hirshberg 1950). In common photochromes, 
photoisomerization either relies on cis-trans-isomerization (e.g. in azobenzene (AB) 
and hemithioindigo (HTI)) or on cyclisation/bond opening (e.g. in spiropyran (SP) or 
diarylethenes (DAE)). For the control of biological molecules the two isomers of the 
photochrome ideally have very different geometries and polarities as it is generally 
assumed that the bigger the transition the more likely it will induce a significant effect. 
In the following, we describe important classes of synthetic photochromes that are 
used to manipulate biological processes. 
AB likely is the best studied and most commonly applied photochrome. AB 
undergoes a cis-trans-isomerization around the central nitrogen-nitrogen double 
bond (Figure 1a). Thousands of photocycles can be performed with high quantum 
yield, on remarkably short time scales and without signs of fatigue or toxic side 
products. These properties collectively make AB a well-suited photochrome for 
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biology. Trans-AB is the dominant isomer at equilibrium in the dark. 
Photoisomerization to cis-AB is typically initiated using UV light (~360nm) and the 
relaxation can either occur thermally or be catalysed by blue or green light 
(~500nm) (Rau 1973). Complete photoisomerization cannot be achieved as the 
absorption spectra of the two isomers overlap and photostationary states always 
contain mixtures of cis- and trans-isomers. While unmodified AB shows thermal cis-
trans-relaxation on the timescale of days at room temperature, AB with red-shifted 
absorption maxima relax within seconds to minutes (also see Sections 6.4.1 and 
6.4.2). The photoisomerization of AB is accompanied by changes in structure: The 
two benzyl rings of the cis-isomer are roughly tilted by 55°, while in the trans-isomer 
both rings lie in a plane. The end-to-end distance (measured between the two para-
positions of the benzyl rings) decreases by about 3.5Å, and modified ABs were 
synthetized to maximize this distance without generating additional degrees of 
conformational freedom (Beharry and Woolley 2011; Samanta and Woolley 2011; 
Standaert and Park 2006). 
While not yet combined to ion channels, we briefly introduce other types of 
photochromes that are applied in biology and likely to transition to ion channel 
research in the future. SPs consist of two ring systems joined at a quaternary spiro-
carbon atom (Figure 1b). The twisted and colourless SPs can be converted into the 
planar and purple coloured merocyanines (MCs) using UV light that breaks the spiro-
carbon-oxygen bond (Aldoshin 1990; Berkovic et al. 2000). Relaxation to the 
thermodynamically favoured SP can be accelerated by green light or occurs 
thermally. Large changes in geometry and polarity, compatibility with two-photon 
excitation and fluorescence of the MC isomer make SPs attractive photochromes for 
biological applications (Mao et al. 2008; Marriott et al. 2008; Petchprayoon et al. 
2011). HTIs were synthesized and studied in detail recently (Figure 1c) (Cordes et 
al. 2007; Eggers et al. 2001; Herre 2005; Mostoslavskii 1970; Regner et al. 2012). 
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HTIs undergo light-induced isomerization from the thermodynamically favoured Z-
isomer to the corresponding E-isomer and both isomers exhibit a planar structure. In 
contrast to AB and SP, both the photoisomerization and thermal relaxation can be 
accelerated by visible light. Finally, DAE and fulgides/fulgimides show potential for 
applications in biological research (Figure 1d) (Chen et al. 2011; Fujimoto et al. 
2012). These hexatriene compounds undergo light-induced and reversible 
electrocyclic ring closure and opening (Irie 2000; Yokoyama 2000). While the ring 
closing requires UV light the opening can be triggered by visible light. It is interesting 
to note that both classes show bi-stability as thermal relaxation is negligible. 
 
6.3 Design principles of photochromic ion channel controllers 
6.3.1 PCLs: one-component photopharmacology 
Several complementary designs that build on photochromes have been developed 
for the control of ion channels. PCLs refer to soluble agonists, antagonists and 
modulators with photochromic substituents. Biological activity is retained in one 
isomer but not the other and thereby photoisomerization allows rapid and reversible 
control of ion channel function. In the first design represented by 4-GluAzo, a PCL of 
ionotropic glutamate receptors (iGluRs), the natural ligand is coupled to AB (see 
Section 6.4 for a detailed discussion of 4-GluAzo). Coupling sites are typically 
chosen with the help of model molecules with lipophilic tails that test how coupling 
affects affinity and solubility. In the design represented by AP2, a PCL of GABAA 
receptors (GABAARs), the aromatic group of the ligand propofol is incorporated in 
AB. Also for this design model compounds are useful, and often model compounds 
have already been described in literature (e.g. LY339434 in the case of 4-GluAzo or 
p-4-AziC5-propofol in the case of AP2) (Figure 2a) (also see Section 6.4.1). PCLs 
are ‘drug-like’ in that they diffuse in tissue and offer similar specificities for ion 
channels as natural ligands. However, they are advantageous in specific 
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applications, as spatial and temporal precision can be obtained that surpasses that of 
normal pharmacology. 
 
6.3.2 PTLs: ligands-on-a-leash 
In contrast to PCLs, PTLs target genetically modified ion channels through covalent 
attachment. The majority of published PTLs consist of AB, maleimide (Mal) as the 
reactive group for site-specific attachment and a specific ligand group (agonists, 
antagonists or modulators) (Figure 2b). Cysteine (Cys) residues are commonly used 
as attachment sites of PTLs for two major reasons. First, Cys can be easily 
introduced into a protein by specific mutation and second, the thiol group is a well-
known and highly reactive nucleophile (also see Chapters 2 and 5 of this book). 
PTLs have many of the attributes of PCLs but due to genetic modification they 
enable the construction of orthogonal ligand-protein-pairs and offer specific control 
over selected ion channel subtypes. In contrast to PCLs, PTLs are a two-component 
system that requires introduction of the Cys substitution and expression of the 
modified ion channel followed by application of the PTL. 
 
6.3.3 PXs: molecular tweezers 
An exciting new development for the optical control of ion channels are PXs, which 
bind amino acids located in two distant parts of the protein through functional groups 
located at the ends of the photochrome (Figure 2c) (Browne et al. 2014). Non-
isomerizable bi-functional crosslinkers have for decades been applied in molecular 
and structural biology as ‘molecular rulers’ during protein function and protein 
assembly (Fasold et al. 1971; Ji 1983). In 2000, Woolley and colleagues introduced 
crosslinkers that contain a central AB moiety for the optical control of the secondary 
structure of peptides. This principle was recently applied to P2X ion channels, where 
photoisomerization of AB resulted in a change of crosslinker length and 
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conformational changes leading to channel opening (Browne et al. 2014; Kumita et 
al. 2000). 
 
6.4 Applications of PCLs and PTLs 
6.4.1 PCLs of ligand-gated ion channels 
The first PCLs were designed and synthesized in the 1960s and 1970s in the form of 
AB-substituted acetylcholines and carbachols. These molecules were mono- or bi-
functional with a quaternary ammonium (QA) and were applied to control nicotinic 
acetylcholine receptors (nAChRs) and acetylcholine esterase to study kinetics of ion 
channel activation and membrane potential shifts in excitable tissue (Bartels et al. 
1971; Bieth et al. 1969; Deal et al. 1969; Chabala et al. 1985; Lester et al. 1979; 
Nargeot et al. 1982). Despite these early successful examples for the optical control 
of ion channel function, further design and application of PCLs was not revisited until 
nearly three decades later. The first molecule to follow was 4-GluAzo, a PCL 
designed for the Kainate receptor-subfamily (KAR) of tetrameric iGluRs. With its 
lipophilic tail, 4-GluAzo resembles LY339434 and discriminates between GluK1 and 
GluK2 subtypes in a heterologous expression system (Volgraf et al. 2007). 4-GluAzo 
is more active in its trans-isomer but exhibits markedly reduced potency and efficacy 
compared to glutamate (Glu). A recent crystal structure of the GluK2 ligand-binding 
domain (LBD) in complex with 4-GluAzo confirmed several hypothesis made during 
the design of 4-GluAzo (Reiter et al. 2013). The structure confirmed that the Glu 
moiety of 4-GluAzo indeed forms those contacts to the ligand-binding pocket that 
were previously observed for Glu. The structure also revealed that the lipophilic tail 
protrudes to the protein surface with the formation of additional PCL-protein contacts. 
Finally, the structure allowed attributing the reduced efficacy to a more limited 
conformational change of the GluK2 LBD that is characteristic for partial agonists. 
The clamshell-like LBD of iGluRs is of prokaryotic origin and shared amongst the 
three major iGluR subfamilies (AMPA receptors (AMPAR), KARs and NMDA 
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receptors (NMDARs)) (Mayer 2011; Janovjak et al. 2011). However, sufficient 
structural differences exist between the subfamilies and these differences prevented 
the direct application or even modification of 4-GluAzo as a PCL of AMPARs and 
NMDARs. To functionally discriminate between AMPAR and other iGluRs, 
BnTetAMPA, a highly specific AMPAR agonist with a lipophilic tail was derivatized 
into AB-tetrazolyl-AMPA-3 (ATA-3) (Stawski et al. 2012). Like 4-GluAzo, ATA-3 is 
functionally active in its dark-adapted trans-isomer. Both 4-GluAzo and ATA-3 are 
capable of triggering trains of action potentials (APs) in primary neurons by activating 
endogenous iGluRs. 
UV light, which is required for trans-cis-isomerization of unmodified AB, may harm 
biological samples and exhibits limited depth of tissue penetration. An important 
advance in the design of PCLs is thus the development of molecules that react to 
visible light, which can be achieved by increasing the electron density at the AB 
using substituents. For instance, trans-cis-isomerization of ATA-3 occurs readily in 
blue light because of an electron-donating para-dimethylamino substituent (Stawski 
et al. 2012). Notably, unlike unmodified AB that thermally relaxes to its trans-isomer 
on the time scale of many minutes to hours, such modified ABs relax within seconds. 
Similar improvements in wavelength sensitivity and thermal relaxation were also 
achieved in PCLs of voltage gated ion channels and exploited for restoration of 
retinal function (see Section 6.4.2). 
A recent variation of PCLs encompasses molecules with the ability to tune the 
conductance of ligand-gated ion channels rather than to directly control channel 
opening or closing. Two potentiating PCLs have been developed for pentameric 
GABAARs and applied in heterologous expression systems, primary cells and a 
tadpole model system (Stein et al. 2012; Yue et al. 2012). AP2 and MPC088 are both 
AB derivatives of propofol, a common amnestic agent and powerful positive allosteric 
GABAAR modulator. However, in contrast to MPC0888, in which AB is conventionally 
coupled to propofol, a new approach was chosen in AP2 by incorporating the phenol 
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of propofol into the photochrome (Figures 2 and 3). Both PCLs potentiate GABAARs 
in the trans-isomer and remarkably with higher potency but reduced efficacy 
compared to the parent molecule (Stein et al. 2012; Yue et al. 2012). The 
development of AP2 also highlighted that synthesis and functional evaluation of 
many PCL candidates with varying substituents can be required to discover 
molecules with desired combined photophysical and functional properties. 
 
6.4.2 PCLs of voltage-gated ion channels 
Mono-functional and bi-functional PCLs have been developed to act on voltage-
gated ion channels. These molecules contain QA ions and resemble both the QA 
PCLs developed in the 1960s and 1970s (see above) as well as lidocaine or QX-314 
(Binshtok et al. 2007). A family of mono-functional AB-QA molecules binds to the 
tetraethylammonium (TEA) binding site on the inner cavity of Kv channels and 
functions as open channel blockers (Banghart et al. 2009; Mourot et al. 2011). 
Experimental evaluation of several AB-QA compounds, including acrylamide-AB-QA 
(AAQ) and benzoyl-AB-QA (BzAQ), revealed that the length and composition of the 
lipophilic tail influences potency. Similarly to the PCLs described above, AB-QA 
compounds were developed that contain modified ABs and are isomerized by visible 
light with more rapid thermal relaxation (Fehrentz et al. 2012; Mourot et al. 2011). 
Notably, the green light-sensitive diethylamino-AB-QA (DENAQ) is capable of 
restoring functional light sensitivity in rat retinas with degenerated photoreceptors 
(Polosukhina et al. 2012; Tochitsky et al. 2014). 
A second family of PCLs of voltage-gated ion channels is bi-functional and 
represented by the prototypical QA–AB–QA (QAQ). QAQ also resembles the early 
compound bis-Q (Bartels et al. 1971) and effectively blocks voltage-gated Na+, K+ 
and Ca2+ channels in its trans-isomer (Figure 4) (Mourot et al. 2012). The two 
permanent charges of QAQ prohibit passive entry into the cells and make QAQ 
reliant on TRPV1 and P2X7 receptors as an entry route. This entry route allows 
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selecting for neurons that are being activated by pain stimuli, and thus QAQ can 
function like an optical local anaesthetic while sparing other sensory modalities 
(Mourot et al. 2012). 
 
6.4.3 PTLs of ligand-gated ion channels 
With the help of a lipophilic Glu-derivative that served as a model molecule, a family 
of Mal-AB-Glu (MAG) PTLs was developed for the specific control of KARs (Volgraf 
et al. 2006) (Figure 2). GluK2 was the first ion channel to be gated by MAGs and 
both the length of MAGs as well as the attachment site were shown to determine 
whether the channels are opened by UV light (cis-MAG) or visible light (trans-MAG) 
(Volgraf et al. 2006; Numano et al. 2009). Application of two ion channels with this 
‘sign inversion’ allows experimenters to target two separate neuronal populations, 
and such experiments are further supported by modified MAGs with trans-cis-
isomerization in response to visible light and rapid thermal relaxation (Kienzler et al. 
2013). The light-gated iGluR (LiGluR; GluK2-MAG) was converted from an excitatory 
channel to an inhibitory channel (HyLighter) by incorporating the transmembrane 
domain of a prokaryotic K+-selective amino acid receptor (Janovjak et al. 2010). 
While LiGluR is capable of activating neurons in culture and in vivo with millisecond 
time resolution, HyLighter is capable of hyperpolarization and neuronal silencing 
(Szobota et al. 2007; Janovjak et al. 2010). LiGluR has been used to evoke 
transmitter release in glial cells and chromaffin cells, to conduct neural circuit 
analysis and restore a retinal light response and visual behaviour to mice with 
degenerated photoreceptor cells (Caporale et al. 2011; Izquierdo-Serra et al. 2013; Li 
et al. 2012; Wyart et al. 2009). 
Many years before the development of MAGs, a set of classic studies revealed a first 
PTL of pentameric ligand gated ion channels. Bromomethyl-AB-QA (QBr) attached to 
a native Cys of endogenous nAChRs and enabled selective channel opening in its 
trans-isomer (Bartels et al. 1971). QBr was subsequently applied to study ion 
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channel activation kinetics in Electrophorus electroplaques and rat myoballs 
(Chabala and Lester 1986; Lester et al. 1980). Unlike QBr, which was not targeted by 
genetic manipulation, recent PTLs were designed to act as an agonist (Mal–AB–
acylcholine (MAACh)) or antagonist (Mal–AB–homocholine (MAHoCh)) on 
genetically engineered nAChRs (Figure 5) (Tochitsky et al. 2012). The basis for the 
development of light-activated nAChRs was, similarly to the development of LiGluR 
and recent light-activated metabotropic Glu receptors (Levitz et al. 2013), a 
combination of Cys-scanning mutagenesis and molecular modelling. 
 
6.4.4 PTLs of voltage-gated ion channels 
The design of the Mal-AB-QA (MAQ) PTL enabled the development of the 
hyperpolarizing synthetic photoisomerizable AB-regulated K+ channel (H-SPARK), 
the first optical tool that could effectively silence a neuronal population (Banghart et 
al. 2004). In H-SPARK, the Shaker K+ channel was optimized for the PTL by 
reducing inactivation and by shifting its voltage dependence to resting potentials. 
Expression of the channel results in a high conductance that is blocked by MAQ in its 
trans-isomer (Banghart et al. 2004). The excitatory counterpart to H-SPARK, 
depolarizing SPARK (D-SPARK), was developed shortly after, and in the meantime 
MAQ has proven to be a potent PTL of a number of K+-selective channels, including 
leak channels and channels that are opened by intracellular Ca2+ (Chambers et al. 
2006; Fortin et al. 2011; Sandoz et al. 2012). 
Genetic ‘knock-in’ or ‘knock-out’ or subtype specific pharmacology are the classic 
approaches to dissect the functional role of selected ion channels in vivo. MAQ 
enabled the creation of a complementary approach called ‘subunit replacement 
strategy’ using photoswitchable conditional subunits (PCS) (Sandoz et al. 2012). The 
PCS is an engineered ion channel subunit that has been modified for gating by a 
PTL but cannot be trafficked to the membrane without the presence of a native 
subunit. Through this trick, only cells that express native subunits are 
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photosensitized and the currents under light control are not subject to 
overexpression. Collectively, subunit replacement strategy represents a functional 
knock-in (Figure 6) (Sandoz et al. 2012), and a PCS of the K2P channel TREK-1 
revealed that this channel is a target of modulation by G-protein coupled receptor 
signaling (Sandoz et al. 2012). 
 
6.5 Outlook 
By combining chemical synthesis, photophysics and biophysics, the fields of 
photopharmacology and optochemical genetics have produced photochromic ion 
channel controllers that function with striking potency and specificity. The versatility 
of these photoswitches includes (i) sign inversion, which may enable dissecting 
effects of one ion channel type versus another (Section 6.4.3), (ii) modulation, which 
may decipher how current magnitudes effect signal integration (Section 6.4.1), and 
(iii) photochromes with modified absorption maxima, which may overcome 
experimental limitations associated with UV light and slow thermal relaxation 
(Sections 6.4.1 to 6.4.3). Exciting applications of PCLs and PTLs are emerging and 
include the control of pain sensation (Mourot et al. 2012), the control of visual 
responses (Polosukhina et al. 2012; Tochitsky et al. 2014; Caporale et al. 2011), and 
the identification of the targets of non-ionotropic signaling pathways (Sandoz et al. 
2012). 
We are now able to tailor molecular properties of the photochromic controllers (e.g. 
choice of agonistic or antagonistic ligand groups, choice of photoisomerization 
wavelengths) and of the ion channel (e.g. removal of inactivation) to the extent that 
we are able to rationally design the combined system as a whole. In our contribution 
to a Springer book published three years ago, we envisioned systems that exhibit 
‘gated’ photoresponses. We defined gated systems as those that “only respond to 
light if an additional, external stimulus is present or modulate an external stimulus by 
the conformational effect of light”. While the second of these two types of gated 
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system is beautifully represented by AP2 (Section 6.4.1), the first type still awaits 
realization. 
An ongoing challenge will be to apply photochromic systems in a broader range of 
animal models, in particular to connect channel function to the behaviour of freely 
moving animals. Since PCL and PTLs can behave like small molecule drugs, they 
are able to photosensitize tissue within seconds or minutes in comparison to days in 
the case of genetically targeted optogenetic regulators. Delivery of molecules to 
cortical and deep brain structures in mammalian systems could be achieved by intra-
cranial or cannula injection, which has been used for many years in in vivo analysis 
of connectivity and excitability as well as disease-related drug treatment. 
The PCLs, PTLs and PXs introduced here have been recently complemented by two 
approaches that already address some of the challenges mentioned above. Both 
approaches have in common that they are built on light-sensitive molecules that do 
not incorporate pharmacologically-active ligands. Optovin is a rhodanine-containing 
small molecule that modulates TRPA1 channels in response to violet light. Optovin 
not only responds to visible light but also has been shown to control neurons that 
express TRPA1 channels in vivo (Kokel et al. 2013). PTL-like molecules that were 
designed to directly gate channels by light can control even those channels that lost 
their ability to respond to ligands and in addition promise to be of general applicability 
(Lemoine et al. 2013). 
In line with voltage-gated and ligand-gated ion channels being essential for all 
information flow within and between neurons, photochromic ion channel controllers 
have been most commonly used to enhance or inhibit neuronal signalling. However, 
PCLs, PTL and PXs are also of potential relevance for a number of fields other than 
neuroscience. Voltage-gated and ligand-gated ion channels are involved in a 
plethora of physiological processes, ranging from metabolism (e.g. insulin secretion 
in pancreatic -cells driven by membrane currents) to cancer (e.g. cell proliferation 
linked ion flow). It should be possible to adapt what has been built and tested on 
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neurons to open new avenues in these research areas. Specifically the research 
presented here can irradiate to these disciplines by (i) either providing highly efficient 
molecular tools or (ii) by providing guidance for the development of new molecular 
tools for non-ion channel targets. For instance, a PTL designed for metabotropic Glu 
receptor is similar to MAG and produced rapid and reproducible induction of G-
protein coupled signals (Levitz et al. 2013). 
It is often noted that the fascinating developments leading to the optical control of ion 
channels started with the collaboration of specialists from different disciplines. Most 
commonly chemistry and biophysics are emphasized. Thus this research provides an 
exciting basis for the continued education of future generations of graduate students 
and postdocs that will be familiar with chemical synthesis, electrophysiology and 
molecular modelling. This chapter has highlighted that photochromic ion channel 
controllers have high potential and harvesting this potential may require scientists 
from other disciplines, in particular pharmacologists and physiologists, to also play 
role. 
  




Figure 1. Prominent photochromes applied to manipulate biological molecules 
See main text for a detailed description of each photochrome. 
 
Figure 2. Main classes of photochromic ion channel controllers 
(a) In PCLs (here: AP2), AB is either partly incorporated into a ligand or tethered to a 
ligand (here: incorporated into propofol). AP2 was developed with the help of p-4-
aziC2-propofol, which served as a ‘tether model’ to test for potency and solubility of 
the ligand derivative. AP2 potentiates GABA-induced currents of GABAARs in its 
trans-isomer (also see Section 6.4.1). 
(b) In PTLs (here: MAG), AB is tethered to a native ligand (here: Glu) and a Cys-
reactive group (here: Mal). MAG was developed with the help of the lipophilic Glu-
derivative ‘tether model 3’. MAG activates KARs in its cis-isomer but not trans-isomer 
or vice versa depending on attachment site of MAG (grey star denotes Cys 
substitution) (also see Section 6.4.3). 
(c) PXs are molecular tweezers that function without the need of pharmacologically-
active ligand moieties. In BMA, the aliphatic chain of the non-isomerizable model 
crosslinker bismaleimidohexane is replaced by AB. BMA enforced open channel 
conformations in trimeric ion channels. 
 
Figure 3. MPC088, a modulating PCL of GABAARs 
(a) MPC088, here shown in its active trans-isomer, acts as a photochromic 
potentiator of GABAARs. 
(b) At high concentrations, trans-MPC088 gates GABAARs, while at low 
concentrations, GABA currents are potentiated by trans-MPC088. 
(c) Representative current traces recorded from X. laevis oocytes expressing 122 
GABAARs at increasing concentrations of trans-MPC088. 
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(d) Representative current traces recorded from X. laevis oocytes expressing 122 
GABAARs at increasing concentrations of trans-MPC088 co-applied with 3μM GABA. 
Part c and d is reprinted by permission from Macmillan Publishers Ltd: Nature 
Communications (Yue et al. 2012), copyright 2012. 
 
Figure 4. QAQ, a PCL of voltage-gated cation channels 
(a) QAQ, here shown in its active trans-isomer, acts as a blocker of voltage-gated 
cation channels. 
(b) QAQ enters cells through TRPV1 or P2X ion channels upon activation by noxious 
stimuli and is active at various ion channel targets (c). 
(d) Representative current traces recorded during AP firing in a mammalian neuron 
with QAQ applied on the intracellular side. Firing rate normally increases with 
increasing current injection (magenta trace) and this increase is blocked in response 
to 500nm light (green trace). 
Part c and d is reprinted by permission from Macmillan Publishers Ltd: Nature 
Methods (Mourot et al. 2012), copyright 2012. 
 
Figure 5. MAACh and MAHoCh, agonistic and antagonistic PTLs of nAChRs 
(a) MAACh and MAHoCh, here shown in their active cis-isomer, act as an agonist 
and antagonist of nAChRs. 
(b) Genetically engineered nAChRs (grey star denotes Cys substitution) are able to 
bind either MAACh or MAHoCh resulting in activation or competitive inhibition. 
(c) Representative current trace recorded from X. laevis oocytes expressing 34 
E61C nAChRs functionalized with MAACh. Currents are elicited by 380nm light 
(magenta lines) and turned off by 500nm light (green lines). 
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(d) Representative current trace recorded from X. laevis oocytes expressing 34 
E61C AChRs functionalized with MAHoCh. Currents elicited by ACh are reduced in 
response to 380nm light (magenta lines) but not 500nm light (green lines). 
Part c and d is reprinted by permission from Macmillan Publishers Ltd: Nature 
Chemistry (Tochitsky et al. 2012), copyright 2012. 
 
Figure 6. ‘Subunit replacement strategy’ based on MAQ, a PTL of K+ channels 
(a) MAQ, here shown in its active cis-isomer, acts as a blocker of K+ channels. 
(b) PCS (orange) has been altered for PTL attachment and for impaired trafficking to 
the plasma membrane. In TREK1, retention was achieved by deletion of the C-
terminus. As PCS and native subunits (green) assemble, the complex is transported 
to the membrane and, in this way, currents that resemble endogenous currents are 
under optical control. 
(c) Representative current trace recorded from HEK293 cells expressing TREK1-
PCS. Illumination with 380nm light (magenta lines) and 500nm light (green lines) 
reversibly blocks and releases block of outward current preceding (top) and following 
GABA application (bottom). 
(d) Representative current trace for photomodulation of spontaneous firing in 
hippocampal neurons expressing TREK1-PCS (left). Firing rate averaged over time 
(min) during phasic illumination with 500nm and 380nm light (right). 
Part c and d is reprinted from Neuron (Sandoz et al. 2012), Copyright 2012, with 
permission from Elsevier Ltd. 
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